Amanda Y Wang Selected Research

Amanda Y Wang Research Topics

7	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 10/2014
5	Chronic Renal Insufficiency 03/2023 - 10/2014
5	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2021 - 11/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 11/2013
2	Sepsis (Septicemia) 01/2022 - 09/2019
2	Heart Failure 01/2021 - 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 09/2021
1	Cerebral Infarction 01/2021
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Nephrogenic Diabetes Insipidus 01/2021
1	Anemia 01/2021
1	Hyperkalemia 01/2021
1	Myocardial Infarction 01/2021
1	Proteinuria 02/2020
1	COVID-19 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Fibrosis (Cirrhosis) 12/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Obesity 07/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2014
1	Thrombosis (Thrombus) 11/2013
1	Hemorrhage 11/2013

3	HLA-DQA1 antigen (HLA DQA1)IBA 05/2021 - 09/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 09/2019
2	Phospholipase A2 ReceptorsIBA 01/2021 - 09/2019
1	Factor XIII (Coagulation Factor XIII)IBA 01/2022
1	ThrombomodulinIBA 01/2022
1	Histocompatibility Antigens Class IIIBA 09/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	roxadustatIBA 01/2021
1	CreatinineIBA 01/2021
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021
1	Sulfamethoxazole FDA LinkGeneric 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020
1	GlucocorticoidsIBA 02/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2020
1	VaccinesIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019
1	ORALIT (ORS)IBA 12/2018
1	AntigensIBA 11/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Circular RNAIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2014
1	AnticoagulantsIBA 11/2013
1	Warfarin (Coumadin)FDA LinkGeneric 11/2013

4	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2024 - 01/2020
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2019
2	Therapeutics 01/2020 - 07/2015
1	Perioperative Period 12/2022
1	Resuscitation 01/2022
1	Hemofiltration 06/2014
1	Hemodiafiltration 06/2014
1	Renal Dialysis (Hemodialysis) 06/2014
1	Catheters 11/2013